Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U51909DL2014PTC264328 Incorporated 01 February 2014 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹18.04 Lakh
▼ 0.35% YoY
Net profit · FY 2025
₹1.66 Lakh
Net margin 9.2%
EBITDA · FY 2025
₹2.26 Lakh
EBITDA margin 12.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Synthokind Pharmaceuticals Private Limited

Data last updated:

Synthokind Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 February 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2014PTC264328. Its GSTIN is 07AAUCS3857N1ZC (Delhi).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Veena Mittal and Amit Mittal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.488 02nd Floor Near Rana Public School Shahbad Daulatp, Ur, Delhi, India – 110042.

As per the financials filed for FY 2025, the company reported a revenue of ₹18.04 Lakh. For the same year it recorded a net profit of ₹1.66 Lakh (net margin 9.2%) and EBITDA of ₹2.26 Lakh (EBITDA margin 12.5%). Revenue has grown at a compounded annual rate (CAGR) of 19% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Synthokind Pharmaceuticals Private Limited
CIN U51909DL2014PTC264328
Registration Number 264328
Incorporation Date 01 February 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    House No.488 02nd Floor Near Rana Public School Shahbad Daulatp, Ur, Delhi, India – 110042
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Synthokind Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Synthokind Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Synthokind Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Synthokind Pharmaceuticals Private Limited

The main business activity of Synthokind Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Synthokind Pharmaceuticals Private Limited FY 2025 filings available

Synthokind Pharmaceuticals Private Limited reported revenue of ₹18.04 Lakh for FY 2025.

Revenue · FY 2025
₹18.04 Lakh
Net profit · FY 2025
₹1.66 Lakh margin 9.2%
EBITDA · FY 2025
₹2.26 Lakh margin 12.5%

Compounded Annual Growth Rate (CAGR) of Synthokind Pharmaceuticals Private Limited

Revenue CAGR growth
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 10%
5 years · compounded
▲ 58%

Revenue has grown at a compounded annual rate (CAGR) of 19% over five years. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Synthokind Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹2.26 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.66 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Synthokind Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin12.5%••••••••••••••••
Net Profit Margin9.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Synthokind Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Cis Medtour Private Limited••••••••••••••••-New Delhi, Delhi, India
Medansa Pharmaceuticals Private Limited••••••••••••••••-South Delhi, Delhi, India
Creata Pharmaceuticals (I) Private Limited••••••••••••••••-Lucknow, Uttar Pradesh, India
Habeeba Pharmaceuticals Private Limited••••••••••••••••-Pune, Maharashtra, India
Rollvet Pharmaceuticals Private Limited••••••••••••••••-Varanasi, Uttar Pradesh, India
Synthokind Pharmaceuticals Private Limited this company••••••••••••••••-Delhi, India
Recure Healthcare Private Limited••••••••••••••••-Rajkot, Gujarat, India
Shantilal & Co Pharma Private Limited••••••••••••••••-Chennai, Tamil Nadu, India
Dia Herbal Healths Pharmaceuticals Private Limited••••••••••••••••-Kottayam, Kerala, India
Brunson Healthcare Private Limited••••••••••••••••-Kalyan West, Maharashtra, India
Aresko Global Private Limited••••••••••••••••-New Delhi, Delhi, India

Peers are the five companies nearest above and the five nearest below Synthokind Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Auditor Details of Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals Private Limited is audited by ANKIT SK JAIN & CO. for the financial year 2023.

NameStatusAppointment DateCessation Date
ANKIT SK JAIN & CO.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Veena MittalDirector12 Jan 20179 Years 8 MonthsCurrent
Amit MittalAdditional Director26 Mar 20188 Years 6 MonthsCurrent

Ownership and Shareholding of Synthokind Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Synthokind Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Synthokind Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals Private Limited has 6 board changes on record since 2014: 2 appointments and 4 cessations. The latest: Vishav Deep Bansal ceased to be Director on 09 Jul 2018.

AGM
Synthokind Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Synthokind Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Vishav Deep Bansal ceased to be Director.
Appointed
Amit Mittal was appointed as Additional Director.
Ceased
Veena Mittal ceased to be Additional Director.
Ceased
Surender Kumar ceased to be Director.
Appointed
Veena Mittal was appointed as Director.
Ceased
Amardeep Bansal ceased to be Director.
Incorporation
01 Feb 2014
Synthokind Pharmaceuticals Private Limited was registered on 01 Feb 2014 with Roc Delhi & aged 12 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Synthokind Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Synthokind Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Synthokind Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAUCS3857N1ZCDelhiActive28 Apr 2019
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Synthokind Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 February 2014 (12+ years old) and is registered under CIN U51909DL2014PTC264328.

Synthokind Pharmaceuticals reported revenue of ₹18.04 Lakh for FY 2025.

Synthokind Pharmaceuticals has 2 current directors:

Synthokind Pharmaceuticals reported a net profit of ₹1.66 Lakh (net margin 9.2%) and EBITDA of ₹2.26 Lakh (EBITDA margin 12.5%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Synthokind Pharmaceuticals is 19% over five years. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Synthokind Pharmaceuticals is 07AAUCS3857N1ZC, registered in Delhi.

The CIN (Corporate Identification Number) of Synthokind Pharmaceuticals is U51909DL2014PTC264328. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Synthokind Pharmaceuticals was incorporated on 01 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Synthokind Pharmaceuticals by revenue are Cis Medtour Private Limited, Medansa Pharmaceuticals Private Limited, Creata Pharmaceuticals (I) Private Limited, Habeeba Pharmaceuticals Private Limited, Rollvet Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).

Vishav Deep Bansal ceased to be Director on 09 Jul 2018. Amit Mittal was appointed as Additional Director on 26 Mar 2018. Veena Mittal ceased to be Additional Director on 30 Sep 2017. Synthokind Pharmaceuticals has 6 board changes on record in total.

The registered office of Synthokind Pharmaceuticals is at House No.488 02nd Floor Near Rana Public School Shahbad Daulatp, Ur, Delhi, India – 110042.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available